Abstract
BACKGROUND: Although newly diagnosed high-grade glioma patients in Japan can receive bevacizumab (BEV) as first-line chemotherapy. randomized clinical......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
